Vitamin D receptor and megalin gene polymorphisms and their associations with longitudinal cognitive change in US adults
- PMID: 22170372
- PMCID: PMC3238459
- DOI: 10.3945/ajcn.111.017137
Vitamin D receptor and megalin gene polymorphisms and their associations with longitudinal cognitive change in US adults
Abstract
Background: Vitamin D receptor (VDR) and the megalin gene polymorphism's link with longitudinal cognitive change remains unclear.
Objective: The associations of single nucleotide polymorphisms (SNPs) for VDR [rs11568820 (CdX-2:T/C), rs1544410 (BsmI:G/A), rs7975232 (ApaI:A/C), rs731236 (TaqI:G/A)], and Megalin (rs3755166:G/A; rs2075252:C/T; rs4668123:C/T) genes with longitudinal cognitive performance changes were examined.
Design: Data from 702 non-Hispanic white participants in the Baltimore Longitudinal Study of Aging were used. Longitudinal annual rates of cognitive change (LARCCs) between age 50 y and the individual mean follow-up age were predicted with linear mixed models by using all cognitive score time points (prediction I) or time points before dementia onset (prediction II). Latent class, haplotype, and ordinary least squares (OLS) regression analyses were conducted.
Results: Among key findings, in OLS models with SNP latent classes as predictors for LARCCs, Megalin(2) [rs3755166(-)/rs2075252(TT)/rs4668123(T-)] compared with Megalin(1) [rs3755166(-)/rs2075252(CC)/rs4668123(-)] was associated with greater decline among men for verbal memory (prediction II). Significant sex differences were also found for SNP haplotype (SNPHAP). In women, VDR(1) [BsmI(G-)/ApaI(C-)/TaqI(A-); baT] was linked to a greater decline in category fluency (prediction I: β = -0.031, P = 0.012). The Megalin(1) SNPHAP (GCC) was related to greater decline among women for verbal memory, immediate recall [California Verbal Learning Test (CVLT), List A; prediction II: β = -0.043, P = 0.006) but to slower decline among men for delayed recall (CVLT-DR: β > 0, P < 0.0125; both predictions). In women, the Megalin(2) SNPHAP (ACC) was associated with slower decline in category fluency (prediction II: β = +0.026, P = 0.005). Another finding was that Megalin SNP rs3755166:G/A was associated with greater decline in global cognition in both sexes combined and in verbal memory in men.
Conclusion: Sex-specific VDR and Megalin gene variations can modify age-related cognitive decline among US adults.
Figures

Similar articles
-
Vitamin D Receptor and Megalin Gene Polymorphisms Are Associated with Longitudinal Cognitive Change among African-American Urban Adults.J Nutr. 2017 Jun;147(6):1048-1062. doi: 10.3945/jn.116.244962. Epub 2017 Apr 26. J Nutr. 2017. PMID: 28446629 Free PMC article.
-
Vitamin D receptor and megalin gene polymorphisms are associated with central adiposity status and changes among US adults.J Nutr Sci. 2013 Oct 30;2:e33. doi: 10.1017/jns.2013.19. eCollection 2013. J Nutr Sci. 2013. PMID: 25191583 Free PMC article.
-
Vitamin D Metabolism-Related Gene Haplotypes and Their Association with Metabolic Disturbances Among African-American Urban Adults.Sci Rep. 2018 May 23;8(1):8035. doi: 10.1038/s41598-018-26230-w. Sci Rep. 2018. PMID: 29795187 Free PMC article.
-
Vitamin D receptor ApaI (rs7975232), BsmI (rs1544410), Fok1 (rs2228570), and TaqI (rs731236) gene polymorphisms and susceptibility to pulmonary tuberculosis in an Iranian population: A systematic review and meta-analysis.J Microbiol Immunol Infect. 2020 Dec;53(6):827-835. doi: 10.1016/j.jmii.2019.08.011. Epub 2019 Sep 28. J Microbiol Immunol Infect. 2020. PMID: 31740220
-
Vitamin D Receptor Gene Polymorphisms and Risk of Alzheimer Disease and Mild Cognitive Impairment: A Systematic Review and Meta-Analysis.Adv Nutr. 2021 Dec 1;12(6):2255-2264. doi: 10.1093/advances/nmab074. Adv Nutr. 2021. PMID: 34167149 Free PMC article.
Cited by
-
The role of vitamin D in Alzheimer's disease: possible genetic and cell signaling mechanisms.Am J Alzheimers Dis Other Demen. 2013 Mar;28(2):126-36. doi: 10.1177/1533317512473196. Epub 2013 Jan 15. Am J Alzheimers Dis Other Demen. 2013. PMID: 23322908 Free PMC article. Review.
-
Vitamin D, Cognition and Alzheimer's Disease: The Therapeutic Benefit is in the D-Tails.J Alzheimers Dis. 2016 May 11;53(2):419-44. doi: 10.3233/JAD-150943. J Alzheimers Dis. 2016. PMID: 27176073 Free PMC article. Review.
-
The Efficacy of Vitamin D Supplementation in Patients With Alzheimer's Disease in Preventing Cognitive Decline: A Systematic Review.Cureus. 2022 Nov 20;14(11):e31710. doi: 10.7759/cureus.31710. eCollection 2022 Nov. Cureus. 2022. PMID: 36569670 Free PMC article. Review.
-
Vitamin D levels, brain volume, and genetic architecture in patients with psychosis.PLoS One. 2018 Aug 24;13(8):e0200250. doi: 10.1371/journal.pone.0200250. eCollection 2018. PLoS One. 2018. PMID: 30142216 Free PMC article.
-
Association of vitamin D receptor gene haplotypes with late-onset Alzheimer's disease in a Southeastern European Caucasian population.Exp Ther Med. 2022 Jul 19;24(3):584. doi: 10.3892/etm.2022.11521. eCollection 2022 Sep. Exp Ther Med. 2022. PMID: 35949319 Free PMC article.
References
-
- Brown J, Bianco JI, McGrath JJ, Eyles DW. 1,25-Dihydroxyvitamin D3 induces nerve growth factor, promotes neurite outgrowth and inhibits mitosis in embryonic rat hippocampal neurons. Neurosci Lett 2003;343:139–43 - PubMed
-
- Garcion E, Wion-Barbot N, Montero-Menei CN, Berger F, Wion D. New clues about vitamin D functions in the nervous system. Trends Endocrinol Metab 2002;13:100–5 - PubMed
-
- Naveilhan P, Neveu I, Wion D, Brachet P. 1,25-Dihydroxyvitamin D3, an inducer of glial cell line-derived neurotrophic factor. Neuroreport 1996;7:2171–5 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical